SCHEMBL5275652

SCHEMBL5275652

FC(F)(F)c1[c]c2ccccc2c(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.40
KIF11 P52732 3/20 0.33
EPHX2 P34913 1/20 0.31
KDM4E B2RXH2 2/20 0.30
MEN1 O00255 2/20 0.30
ALDH1A1 P00352 2/20 0.30
HPGD P15428 2/20 0.30
KMT2A Q03164 2/20 0.30
HSD17B3 P37058 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
GAA P10253 1/20 0.30
SRC P12931 1/20 0.30
CASP1 P29466 1/20 0.30
CASP7 P55210 1/20 0.30
ATM Q13315 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7304600 0.76 KIF11 (0.36) BACE1KIF11EPHX2KDM4EMEN1
SCHEMBL5381424 0.73 BACE1 (0.34) BACE1KDM4EMEN1KMT2APOLB
SCHEMBL8702316 0.72 BACE1 (0.36) BACE1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL1371562 0.68 KIF11 (0.35) BACE1KIF11KDM4EMEN1ALDH1A1
SCHEMBL4619939 0.68 NPC1 (0.32) LMNASMN1; SMN2ATM
SCHEMBL6066540 0.67 HPRT1 (0.45) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL699268 0.66 KDM4E (0.30) KDM4EMEN1KMT2ALMNAHTT
SCHEMBL456001 0.65 ALDH1A1 (0.32) ALDH1A1HSD17B10
SCHEMBL6066739 0.65 CYP2A6 (0.34) KDM4EMEN1ALDH1A1KMT2ACASP1
SCHEMBL5929222 0.65 ALDH1A1 (0.35) BACE1KIF11KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834537-B2 Compounds as chloride channel blocking agent KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-12-05 US claimed
US-20150148550-A1 NOVEL COMPOUNDS AS CHLORIDE CHANNEL BLOCKING AGENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-05-28 US claimed
US-6509426-B2 Dichloro(1,1'-dimethylsilylenebis(2-methyl-4-(4-methoxyphenyl) -4H-azulenyl))zirconium, for example; can produce polyolefin with high molecular weight and high melting point for extrusion or injection moldability JAPAN POLYCHEM CORPORATION (JP) 2003-01-21 US claimed
US-9834537-B2 Compounds as chloride channel blocking agent KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-12-05 US disclosed
US-20150148550-A1 NOVEL COMPOUNDS AS CHLORIDE CHANNEL BLOCKING AGENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-05-28 US disclosed
EP-1312619-B1 Catalyst for the polymerisation of alpha olefins MITSUBISHI CHEM CORP (JP) 2007-11-14 EP disclosed
US-20060178486-A1 Propylene block copolymer MITSUBISHI CHEMICAL CORPORATION (JP) 2006-08-10 US disclosed
EP-1645576-A1 PROPYLENE BLOCK COPOLYMER Mitsubishi Chemical Corporation (JP) 2006-04-12 EP disclosed
US-6825371-B2 CATALYST FOR POLYMERIZATION OF ALPHA -OLEFIN, WHICH COMPRISES: AN ESSENTIAL COMPONENT (A) OF A TRANSITION METAL COMPOUND, AN ESSENTIAL COMPONENT (B) OF AN ION EXCHANGEABLE LAYER COMPOUND EXCEPT FOR SILICATE, OR AN INORGANIC SILICATE, AND OPTIONAL MITSUBISHI CHEMICAL CORPORATION (JP) 2004-11-30 US disclosed
US-20030166459-A1 Catalysts for polymerization of alpha-olefins, process for producing alpha-olefin polymers, novel transition metal compounds and catalyst components for polymerization of alpha-olefin MITSUBISHI CHEMICAL CORPORATION 2003-09-04 US disclosed
US-6590045-B2 An alpha-olefin polymerization catalysts consists of a transition metal compound; an ion exchangable layer compound except for silicate, or an inorganic silicate MITSUBISHI CHEMICAL CORPORATION (JP) 2003-07-08 US disclosed
US-6252097-B1 Transition metal compounds MITSUBISHI CHEMICAL CORPORATION (JP) 2001-06-26 US disclosed
US-6218558-B1 BRIDGED OXYGEN-, NITROGEN- OR SULFUR-CONTAINING METALLOCENE CATALYST CONTAINING AT LEAST CYCLOPENTADIENE RING FUSED TO A C7-10 RING JAPAN POLYCHEM CORPORATION (JP) 2001-04-17 US disclosed
EP-0963996-A2 Novel transition metal compound, catalyst component for olefin polymerization and process for the preparation of alpha-olefin polymer Japan Polychem Corporation (JP) 1999-12-15 EP disclosed
EP-0653433-B1 Novel transition metal compound, olefin polymerization catalyst component comprising the transition metal compound, olefin polymerization catalyst comprising the olefin polymerization catalyst component, and process for olefin polymerization MITSUI CHEMICALS INC (JP) 1999-01-13 EP disclosed
US-5859272-A METALLOCENES; PRODUCES POLYOLEFINS HAVING A HIGH MELTING POINT AND A HIGH MOLECULAR WEIGHT; HIGH POLYMERIZATION ACTIVITY MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1999-01-12 US disclosed
EP-0846696-A1 Catalyst for polymerization of alpha-olefins Mitsubishi Chemical Corporation (JP) 1998-06-10 EP disclosed
US-5616663-A TRANSITION METAL COMPOUND, ALUMINOXANE, COMPOUND WHICH REACTS WITH TRANSITION METAL COMPOUND TO FORM ION PAIR MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1997-04-01 US disclosed
CN-1033510-C Novel transition metal compound, olefin polymerization catalyst component comprising the transition metal compound, olefin polymerization catalyst comprising the olefin polymerization catalyst comp... MITSUI PETROCHEMICAL IND (JP) 1996-12-11 CN disclosed
EP-0653433-A1 Novel transition metal compound, olefin polymerization catalyst component comprising the transition metal compound, olefin polymerization catalyst comprising the olefin polymerization catalyst component, and process for olefin polymerization MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1995-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150148550-A1 NOVEL COMPOUNDS AS CHLORIDE CHANNEL BLOCKING AGENT CACNB2, CACNB1, CACNB4 BACE1 3249/4885KIF11 2207/4885EPHX2 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.